Bss (balanced salt solution) NDC 0065-0795

NDC codes

FDA NDC Directory

Product NDC (as listed)0065-0795Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00065-0795Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0065-0795-15	00065079515	15 mL in 1 BOTTLE (0065-0795-15)Marketed from Mar 28, 1969
0065-0795-50	00065079550	500 mL in 1 BOTTLE (0065-0795-50)Marketed from Mar 28, 1969

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bss
Generic name (nonproprietary): balanced salt solution
Active ingredients: Sodium chloride — 6.4 mg/mLPotassium chloride — .75 mg/mLCalcium chloride — .48 mg/mLMagnesium chloride — .3 mg/mLSodium acetate — 3.9 mg/mLSodium citrate — 1.7 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Alcon Laboratories, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020742
Marketing start: Mar 28, 1969
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0065-0795_f56f90e2-cd68-445b-b8fb-74a53f0f2ca6SPL ID f56f90e2-cd68-445b-b8fb-74a53f0f2ca6SPL set ID 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92beaRxCUI 806392, 806396UNII 451W47IQ8X, 660YQ98I10, M4I0D6VV5M, 02F3473H9O, 4550K0SC9B, 1Q73Q2JULRUPC 0300650795159
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400065079515 followed by a unit qualifier and the quantity

Package 00065-0795-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 25, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE For use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020742

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020742
Product	Strength	Form · route	Labeler	Product NDC
Bssbalanced salt solution	Sodium chloride 6.4 mg/mL + 5 more ingredients	SolutionOphthalmic	Alcon Laboratories, Inc.	0065-1795